Search - tctmd.com

Displaying 121 - 140 of 585

Sort: Relevancy | Date

1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial

Presentation TCT 2020

1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial

Presenter: Manesh Patel

October 15, 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

October 15, 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

October 14, 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

October 09, 2020

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

October 08, 2020

No Gains From Early Angiography After Cardiac Arrest Without STEMI

News Daily News

No Gains From Early Angiography After Cardiac Arrest Without STEMI

October 06, 2020

ESC and EACTS Announce Review of Left Main Revascularization Guidelines

News Daily News

ESC and EACTS Announce Review of Left Main Revascularization Guidelines

Michael O'Riordan

October 06, 2020

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

News Daily News

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

Michael O'Riordan

September 28, 2020

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

PCI Volumes Rise in US and Japan, but for Different Reasons

News Daily News

PCI Volumes Rise in US and Japan, but for Different Reasons

Michael O'Riordan

September 14, 2020

Simple MIRACLE2 Score Could Help Triage Out-of-Hospital Cardiac Arrest

News Daily News

Simple MIRACLE2 Score Could Help Triage Out-of-Hospital Cardiac Arrest

August 05, 2020

FFR Deferral of Nonculprit Lesions Riskier in ACS vs Stable Angina

News Daily News

FFR Deferral of Nonculprit Lesions Riskier in ACS vs Stable Angina

August 03, 2020

Complete Revascularization May Top Culprit-Only PCI Across ACS Types

News Daily News

Complete Revascularization May Top Culprit-Only PCI Across ACS Types

July 08, 2020

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

News Conference News EuroPCR 2020

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

June 26, 2020

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

News Daily News

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

Yael L. Maxwell

June 03, 2020

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

News Daily News

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

May 08, 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI

News Conference News ACC 2020

A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI

March 29, 2020

News Conference News ACC 2020

More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA

Michael O'Riordan

March 28, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.